Basic Information
| LncRNA/CircRNA Name | LINC00667 |
| Synonyms | NA |
| Region | GRCh38_18:5237826-5246508 |
| Ensemble | ENSG00000263753 |
| Refseq | NR_015389 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | non small cell lung cancer |
| ICD-0-3 | C34 |
| Methods | qPCR, Western blot, Luciferase reporter assay, RIP etc. |
| Sample | cell lines (H1975, H23, H1299 and SPCA1) |
| Expression Pattern | differential expressed |
| Function Description | Knockdown of LINC00667 obstructed the proliferation, migration and angiogenesis in NSCLC.LINC00667 could regulate the expression of VEGFA at posttranscriptional level. |
| Pubmed ID | 32281700 |
| Year | 2020 |
| Title | LINC00667 promotes the proliferation, migration, and pathological angiogenesis in non-small cell lung cancer through stabilizing VEGFA by EIF4A3. |
External Links
| Links for LINC00667 | GenBank HGNC NONCODE |
| Links for non small cell lung cancer | OMIM COSMIC |